VAXART, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9588 USD | -6.00% |
|
+36.00% | +67.39% |
| May. 13 | Transcript : Vaxart, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
| May. 13 | Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 16.73 | 625.1 | 786.9 | 126.1 | 87.09 | 169.6 | - | - |
| Enterprise Value (EV) 1 | 16.73 | 625.1 | 620.4 | 126.1 | 87.09 | 169.6 | 169.6 | 169.6 |
| P/E ratio | -0.41 x | -15.9 x | -10.8 x | -1.14 x | -1 x | -2.12 x | -2.44 x | -3 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.7 x | 154 x | 882 x | 1,179 x | 11.8 x | 11.5 x | 7.34 x | 2.49 x |
| EV / Revenue | 1.7 x | 154 x | 882 x | 1,179 x | 11.8 x | 11.5 x | 7.34 x | 2.49 x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / FCF | - | -25 x | -12.1 x | -1.21 x | - | -2.88 x | -2.71 x | -2.82 x |
| FCF Yield | - | -4% | -8.26% | -82.8% | - | -34.7% | -37% | -35.4% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 47,723 | 109,469 | 125,496 | 131,249 | 152,039 | 176,838 | - | - |
| Reference price 2 | 0.3505 | 5.710 | 6.270 | 0.9609 | 0.5728 | 0.9588 | 0.9588 | 0.9588 |
| Announcement Date | 3/19/20 | 2/25/21 | 2/24/22 | 3/15/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 9.862 | 4.046 | 0.892 | 0.107 | 7.379 | 14.73 | 23.1 | 68.05 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -15.78 | -30.17 | -72.75 | -114.6 | -83.35 | -74.99 | -80.5 | -63.75 |
| Operating Margin | -160.06% | -745.67% | -8,156.05% | -107,090.65% | -1,129.52% | -509% | -348.48% | -93.68% |
| Earnings before Tax (EBT) 1 | -18.16 | -31.98 | -70.36 | -107.7 | -82.2 | -75.13 | -80.63 | -63.05 |
| Net income 1 | -18.64 | -32.22 | -70.47 | -107.8 | -82.46 | -77.53 | -80.63 | -62.1 |
| Net margin | -189.06% | -796.34% | -7,900.22% | -100,708.41% | -1,117.56% | -526.2% | -349.06% | -91.26% |
| EPS 2 | -0.8600 | -0.3600 | -0.5800 | -0.8400 | -0.5700 | -0.4533 | -0.3933 | -0.3200 |
| Free Cash Flow 1 | - | -24.97 | -64.99 | -104.4 | - | -58.81 | -62.66 | -60.03 |
| FCF margin | - | -617.23% | -7,285.76% | -97,551.4% | - | -399.14% | -271.25% | -88.21% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/19/20 | 2/25/21 | 2/24/22 | 3/15/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.074 | 0.085 | - | - | 0.022 | 0.675 | 1.358 | 2.101 | 3.245 | 2.181 | 0.05 | 1.417 | 12.47 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -24.22 | -24.78 | -29.25 | -29.43 | -31.14 | -25.57 | -23.05 | -17.82 | -16.9 | -24.07 | -21.97 | -19.57 | -12.12 |
| Operating Margin | -32,722.97% | -29,148.24% | - | - | -141,536.36% | -3,788.44% | -1,697.57% | -848.26% | -520.8% | -1,103.62% | -43,942% | -1,381.39% | -97.25% |
| Earnings before Tax (EBT) 1 | -20.75 | -25.08 | -29.42 | -29.29 | -23.9 | -25.11 | -22.53 | -17.36 | -17.2 | -24.37 | -22.07 | -19.6 | -12.06 |
| Net income 1 | -20.76 | -25.1 | -29.43 | -29.31 | -23.92 | -25.14 | -22.55 | -17.4 | -17.38 | -24.42 | -22.37 | -20.24 | -13.26 |
| Net margin | -28,059.46% | -29,530.59% | - | - | -108,718.18% | -3,724.44% | -1,660.53% | -828.18% | -535.44% | -1,119.53% | -44,742% | -1,428.44% | -106.34% |
| EPS 2 | -0.1700 | -0.2000 | -0.2300 | -0.2300 | -0.1800 | -0.1900 | -0.1600 | -0.1100 | -0.1200 | -0.1400 | -0.1400 | -0.1200 | -0.0733 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/9/22 | 8/8/22 | 11/8/22 | 3/15/23 | 5/4/23 | 8/3/23 | 11/2/23 | 3/14/24 | 5/13/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | 166 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -25 | -65 | -104 | - | -58.8 | -62.7 | -60 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 1.22 | 5.16 | 9.6 | - | 1.5 | 2.5 | 3.1 |
| Capex / Sales | - | 30.23% | 578.14% | 8,972.9% | - | 10.18% | 10.82% | 4.56% |
| Announcement Date | 3/19/20 | 2/25/21 | 2/24/22 | 3/15/23 | 3/14/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9588
USD
Average target price
5
USD
Spread / Average Target
+421.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +67.39% | 170M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
- Stock Market
- Equities
- VXRT Stock
- Financials Vaxart, Inc.